71288-128 : Clofarabine 1 mg/ml Intravenous Injection


NDC71288-128
Labeler: Meitheal Pharmaceuticals Inc.
Product Type: Human Prescription Drug
Drug Name:  Clofarabine
Dosage Form: Intravenous Injection
Application #: ANDA213461
Rev. Date: 


NDC Package Codes:

  • 71288-128-20: 1 VIAL, SINGLE‑DOSE IN 1 CARTON (71288‑128‑20) > 20 ML IN 1 VIAL, SINGLE‑DOSE

Active Ingredients:

  • Clofarabine

Dosage Strength:

  • 1 mg/mL

Pharmaceutical Classes:

  • Nucleic Acid Synthesis Inhibitors [MoA]
  • Nucleoside Metabolic Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 0955-1746 Clofarabine 1 mg/ml Intravenous Injection by Sanofi-aventis U.S. LLC
  • 43598-309 Clofarabine 1 mg/ml Intravenous Injection by Dr.reddy's Laboratories Inc
  • 49315-003 Clofarabine 1 mg/ml Intravenous Injection by Cadila Healthcare Limited
  • 50742-512 Clofarabine 1 mg/ml Intravenous Injection, Solution by Ingenus Pharmaceuticals, LLC
  • 55150-326 Clofarabine 1 mg/ml Intravenous Injection by Eugia Us LLC
  • 60505-6166 Clofarabine 1 mg/ml Intravenous Injection by Apotex Corp.
  • 63323-572 Clofarabine 1 mg/ml Intravenous Injection by Fresenius-kabi
  • 67457-546 Clofarabine 1 mg/ml Intravenous Injection by Mylan Institutional LLC
  • 68083-386 Clofarabine 1 mg/ml Intravenous Injection by Gland Pharma Limited
  • 70121-1236 Clofarabine 1 mg/ml Intravenous Injection by Amneal Biosciences LLC
  • 72266-108 Clofarabine 1 mg/ml Intravenous Injection by Fosun Pharma USA Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 71288-128 QR Code

< Prev: 71288-127Next: 71288-129 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.